Pfizer CEO: Our vaccine timing had nothing to do with politics – Erie News Now

Pfizer took several interim looks at the data during its vaccine trial, but it did not have enough infections in its test group to gain any meaningful data — until Sunday, Gupta reported. If anything, the data came earlier than expected: In October, Bourla made a comment ?in an open letter on Pfizer’s website, saying,?”Based on our current trial enrollment and dosing pace, we estimate we will reach this milestone in the third week of November.”